View all newsletters
Sign up to our newsletters

Support 110 years of independent journalism.

  1. Culture
  2. Nature
19 June 2014updated 24 Jun 2021 1:00pm

No one will die of a snakebite in Britain this summer. Why?

The most recent snakebite death in the UK was in 1975. If only that were true elsewhere: snakebites kill up to 94,000 people and necessitate hundreds of thousands of amputations every year.

By Michael Brooks

Here’s a prediction for the summer that’s much more reliable than anything you’ll get from the Met Office: in Britain, no one will die of a snakebite. The only venomous snakes on these shores are adders. Not only are their numbers in decline but they are timid and bite as a last resort. Each year, roughly a hundred people are bitten by adders in the UK but as few as 12 people have died in the past century as a result. The most recent death was in 1975.

If only that were true elsewhere. Snakebites kill up to 94,000 people and necessitate hundreds of thousands of amputations every year. Children and young people are most likely to be bitten and in some countries snakes kill as many people as Aids. Globally, the number of fatalities is up to 30 times that of landmines.

One of the biggest problems in treating snakebite is recognising which antivenom is needed. The mechanism by which the venom causes paralysis varies from species to species and giving the wrong antivenom can be worse than useless. Often, victims have to wait for the results of blood tests before the appropriate antivenom can be identified. But research published last month in the Journal of Tropical Medicine shows that it might be possible to create a universal antivenom that can be administered straight away as a simple nasal spray.

Before this paper was published, the universal antivenom neostigmine had already passed a couple of tests. In 2013, researchers injected a volunteer with a venom mimic, which caused a creeping paralysis that moved from the eyes to the diaphragm, causing difficulty in breathing. Twenty minutes after administration of the neostigmine nasal spray, the patient had completely recovered.

The second test was not a controlled experiment. It was carried out on a woman who was hooked up to a life-support machine after a snakebite in India. She had received 30
doses of antivenom but still had facial paralysis. The nasal spray relieved this after 30 minutes. Two weeks later, she was back at work.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com Our Thursday ideas newsletter, delving into philosophy, criticism, and intellectual history. The best way to sign up for The Salvo is via thesalvo.substack.com Stay up to date with NS events, subscription offers & updates. Weekly analysis of the shift to a new economy from the New Statesman's Spotlight on Policy team. The best way to sign up for The Green Transition is via spotlightonpolicy.substack.com
  • Administration / Office
  • Arts and Culture
  • Board Member
  • Business / Corporate Services
  • Client / Customer Services
  • Communications
  • Construction, Works, Engineering
  • Education, Curriculum and Teaching
  • Environment, Conservation and NRM
  • Facility / Grounds Management and Maintenance
  • Finance Management
  • Health - Medical and Nursing Management
  • HR, Training and Organisational Development
  • Information and Communications Technology
  • Information Services, Statistics, Records, Archives
  • Infrastructure Management - Transport, Utilities
  • Legal Officers and Practitioners
  • Librarians and Library Management
  • Management
  • Marketing
  • OH&S, Risk Management
  • Operations Management
  • Planning, Policy, Strategy
  • Printing, Design, Publishing, Web
  • Projects, Programs and Advisors
  • Property, Assets and Fleet Management
  • Public Relations and Media
  • Purchasing and Procurement
  • Quality Management
  • Science and Technical Research and Development
  • Security and Law Enforcement
  • Service Delivery
  • Sport and Recreation
  • Travel, Accommodation, Tourism
  • Wellbeing, Community / Social Services
Visit our privacy Policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

In the latest study, mice were the unfortunate victims. They were given a lethal dose of cobra venom, followed by a single nasal dose of neostigmine ten minutes later. Two-thirds survived. The spray also allowed mice given ten times the lethal dose of cobra venom to survive six times longer than they otherwise would have. This suggests that even when it is not an instant cure, the spray could give people time to get to a hospital.

There’s still a long way to go, however. The researchers weren’t able to check the effectiveness of the nasal spray against different kinds of venom due to “limitations of funding”. Of even more concern is their admission that: “Both the efficacy and optimal uses of . . . therapies for neurotoxic snakebite remain unproven even after decades of widespread use.” In other words, hospitals have antivenoms but nobody is doing the studies that will show us how best to use them and how effective they are.

That’s almost certainly because 98 per cent of snakebite victims live in poverty, and treatment (and thus research) is largely paid by the victims or their family. Many bite victims are left disfigured or unable to work because of amputation or permanent paralysis and have to take out loans, sell livestock or crops and even pull their children out of school to get the cash they need. The World Health Organisation has called snakebites a “neglected threat to public health”. It is time for that neglect to end.

Content from our partners
The promise of prevention
How Labour hopes to make the UK a leader in green energy
Is now the time to rethink health and care for older people? With Age UK

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com Our Thursday ideas newsletter, delving into philosophy, criticism, and intellectual history. The best way to sign up for The Salvo is via thesalvo.substack.com Stay up to date with NS events, subscription offers & updates. Weekly analysis of the shift to a new economy from the New Statesman's Spotlight on Policy team. The best way to sign up for The Green Transition is via spotlightonpolicy.substack.com
  • Administration / Office
  • Arts and Culture
  • Board Member
  • Business / Corporate Services
  • Client / Customer Services
  • Communications
  • Construction, Works, Engineering
  • Education, Curriculum and Teaching
  • Environment, Conservation and NRM
  • Facility / Grounds Management and Maintenance
  • Finance Management
  • Health - Medical and Nursing Management
  • HR, Training and Organisational Development
  • Information and Communications Technology
  • Information Services, Statistics, Records, Archives
  • Infrastructure Management - Transport, Utilities
  • Legal Officers and Practitioners
  • Librarians and Library Management
  • Management
  • Marketing
  • OH&S, Risk Management
  • Operations Management
  • Planning, Policy, Strategy
  • Printing, Design, Publishing, Web
  • Projects, Programs and Advisors
  • Property, Assets and Fleet Management
  • Public Relations and Media
  • Purchasing and Procurement
  • Quality Management
  • Science and Technical Research and Development
  • Security and Law Enforcement
  • Service Delivery
  • Sport and Recreation
  • Travel, Accommodation, Tourism
  • Wellbeing, Community / Social Services
Visit our privacy Policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU